Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate
(21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Alexander I Kolesnikov
- Alexei P Sokolov
- Bekki Mills
- Bruce Moyer
- Callie Goetz
- Christopher Hobbs
- Debjani Pal
- Eddie Lopez Honorato
- Fred List III
- Jeffrey Einkauf
- Jennifer M Pyles
- John Wenzel
- Justin Griswold
- Keith Carver
- Keju An
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mark Loguillo
- Matthew B Stone
- Matt Kurley III
- Mike Zach
- Padhraic L Mulligan
- Richard Howard
- Rodney D Hunt
- Ryan Heldt
- Sandra Davern
- Shannon M Mahurin
- Tao Hong
- Thomas Butcher
- Tomonori Saito
- Tyler Gerczak
- Victor Fanelli

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

A pressure burst feature has been designed and demonstrated for relieving potentially hazardous excess pressure within irradiation capsules used in the ORNL High Flux Isotope Reactor (HFIR).

Sintering additives to improve densification and microstructure control of UN provides a facile approach to producing high quality nuclear fuels.

Neutron scattering experiments cover a large temperature range in which experimenters want to test their samples.

Neutron beams are used around the world to study materials for various purposes.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

The use of Fluidized Bed Chemical Vapor Deposition to coat particles or fibers is inherently slow and capital intensive, as it requires constant modifications to the equipment to account for changes in the characteristics of the substrates to be coated.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.